FTC shows an interest
Executive Summary
Federal Trade Commission filed a "friend of the court" brief in the Bristol/ABI/Ivax case indicating that the agency is investigating the terms of Bristol's licensing agreement for the ABI patent. The patent, covering a Cremophor-free formulation of paclitaxel, was listed by Bristol in mid-August (1"The Pink Sheet" Aug. 21, p. 3)